Summit Therapeutics Inc. (SMMT) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2024 | -$226.00M | +62.9% |
| 2023 | -$609.65M | -745.7% |
| 2022 | -$72.09M | +16.4% |
| 2021 | -$86.19M | -62.0% |
| 2020 | -$53.19M | -1087.1% |
| 2019 | $5.39M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2024 | -$226.00M | +62.9% |
| 2023 | -$609.65M | -745.7% |
| 2022 | -$72.09M | +16.4% |
| 2021 | -$86.19M | -62.0% |
| 2020 | -$53.19M | -1087.1% |
| 2019 | $5.39M | — |